A Phase I Study of Continuous Infusion Immunotoxin IgG-RFB4-SMPT-dgA in Refractory CD22 Positive B-Cell Lymphoma

This study has been completed.

Study NCT00001271 Information provided by National Institutes of Health Clinical Center (CC)

First Received: November 3, 1999 Last Updated: March 3, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	April 2001
Estimated Primary Completion Date:	No date given